Skandinaviska Enskilda Banken AB (publ) - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 289 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$981,543
-34.7%
25,5810.0%0.01%
-28.6%
Q1 2024$1,502,628
-17.6%
25,581
-16.1%
0.01%
-36.4%
Q4 2023$1,824,288
+187584.0%
30,481
+19.2%
0.01%
+83.3%
Q3 2023$972
-63.8%
25,581
-13.1%
0.01%
-66.7%
Q2 2023$2,683
+38.2%
29,4410.0%0.02%
+28.6%
Q1 2023$1,942
+21.8%
29,441
-4.6%
0.01%
+16.7%
Q4 2022$1,595
-99.9%
30,846
-16.8%
0.01%
-40.0%
Q3 2022$2,530,000
+51.0%
37,0540.0%0.02%
+66.7%
Q2 2022$1,676,000
-10.9%
37,0540.0%0.01%
+9.1%
Q1 2022$1,882,00037,0540.01%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 624,962$20,599,00013.29%
Octagon Capital Advisors LP 1,595,911$52,601,00012.95%
Logos Global Management LP 1,450,000$47,792,0003.45%
Avoro Capital Advisors LLC 5,000,000$164,800,0002.59%
Ghost Tree Capital, LLC 200,000$6,592,0001.93%
Integral Health Asset Management, LLC 190,000$6,262,0001.80%
GREAT POINT PARTNERS LLC 200,000$6,592,0001.54%
Aufman Associates Inc 53,642$1,768,0001.45%
Ghost Tree Capital, LLC 150,000$4,944,0001.45%
Altium Capital Management LP 166,700$5,494,0001.44%
View complete list of APELLIS PHARMACEUTICALS INC shareholders